Evidence map›Paper›PMID 38157226›Full record

ArticleBlood advances2024

CD36 regulates factor VIII secretion from liver endothelial cells.

Paula Reventun, Pablo Toledano-Sanz, Nunzio Alcharani, Maria Viskadourou, Alanna C Morrison, Maria Sabater-Lleal, Alisa S Wolberg, Paul S de Vries, Nicholas L Smith, William O Osburn and 2 more

Open access · goldAbstract read
In one paragraph

Article in Blood advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 3 countries.

Paula ReventunDepartment of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD.ORCID 0000-0002-6221-8780
Pablo Toledano-SanzDepartment of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD.ORCID 0000-0002-8347-2227
Nunzio AlcharaniDepartment of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD.ORCID 0000-0002-9477-7712
Maria ViskadourouDepartment of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD.
Alanna C MorrisonDepartment of Epidemiology, Human Genetics, and Environmental Sciences, Human Genetics Center, School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX.
Maria Sabater-LlealUnit of Genomics of Complex Disease, Institut d'Investigació Biomèdica Sant Pau, Barcelona, Spain.ORCID 0000-0002-0128-379X
Alisa S WolbergDepartment of Pathology and Laboratory Medicine and UNC Blood Research Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC.ORCID 0000-0002-2845-2303
Paul S de VriesDepartment of Epidemiology, Human Genetics, and Environmental Sciences, Human Genetics Center, School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX.
Nicholas L SmithDepartment of Epidemiology, University of Washington, Seattle, WA.
William O OsburnDepartment of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD.
Marios ArvanitisDepartment of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD.
Charles J LowensteinDepartment of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD.
Johns Hopkins University · USThe University of Texas Health Science Center at Houston · USKaiser Permanente Washington Health Research Institute · USKarolinska Institutet · SEUniversity of North Carolina at Chapel Hill · US

Funding

CHARGE Consortium: Omics Discovery for CVD and Aging PhenotypesR01HL105756 · NHLBI · UNIVERSITY OF WASHINGTON · PI Bruce M Psaty, NICHOLAS L SMITH · 2011 to 2026
$9.5M
Analysis of Whole Genome Sequence and Hemostasis PhenotypesR01HL139553 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI PAUL STEFAN DE VRIES, Alanna C Morrison · 2018 to 2026
$5.0M
Fibrinogen and Factor XIII in Venous ThrombosisR01HL126974 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Alisa S. Wolberg · 2016 to 2026
$4.4M
Population genomic variation, functional biology, and the risk of venous thrombosisR01HL134894 · NHLBI · UNIVERSITY OF WASHINGTON · PI LOWENSTEIN, CHARLES J, SMITH, NICHOLAS L · 2017 to 2020
$2.9M
Model system of oral contraceptive-induced VTE: integrating genomic, transcriptomic, and proteomic discovery with functional biologyR33HL141791 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI LOWENSTEIN, CHARLES J, SMITH, NICHOLAS L · 2020 to 2022
$2.0M
From genotype to phenotype in a GWAS locus: the role of REST in atherosclerosisK08HL166690 · NHLBI · OHIO STATE UNIVERSITY · PI Marios Arvanitis · 2023 to 2026
$681k
American Heart Association-American Stroke Association 23POST1021300NHLBI NIH HHS K08 HL166690NHLBI NIH HHS R01 HL105756NHLBI NIH HHS R01 HL126974NHLBI NIH HHS R01 HL134894NHLBI NIH HHS R01 HL139553NHLBI NIH HHS R33 HL141791
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Factor VIIIHemostaticsEndothelial CellsEndotheliumHepatocytesLiverFactor VIIIHemostatics

Identifiers

PMID38157226
PMCPMC10787269
OpenAlexW4390429329

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.